Latest Insider Transactions at Adverum Biotechnologies, Inc. (ADVM)
This section provides a real-time view of insider transactions for Adverum Biotechnologies, Inc. (ADVM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adverum Biotechnologies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adverum Biotechnologies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 06
2021
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
680,000
+49.05%
|
-
|
Aug 06
2021
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
220,000
+48.81%
|
-
|
Aug 06
2021
|
Angela Thedinga Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
Aug 06
2021
|
Julie Clark Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+41.45%
|
-
|
Mar 31
2021
|
Dawn Svoronos |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$200,000
$10.02 P/Share
|
Mar 24
2021
|
Patrick Machado |
BUY
Open market or private purchase
|
Direct |
10,000
+10.19%
|
$90,000
$9.92 P/Share
|
Mar 24
2021
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
10,000
+27.55%
|
$90,000
$9.88 P/Share
|
Feb 09
2021
|
Leone D Patterson President and CFO |
SELL
Open market or private sale
|
Direct |
12,533
-5.68%
|
$175,462
$14.12 P/Share
|
Jan 15
2021
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
8,600
+34.55%
|
$94,600
$11.53 P/Share
|
Jan 15
2021
|
Patrick Machado |
BUY
Open market or private purchase
|
Direct |
10,000
+11.34%
|
$110,000
$11.52 P/Share
|
Dec 14
2020
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Direct |
12,783
+40.45%
|
-
|